[HTML][HTML] ASAM clinical considerations: buprenorphine treatment of opioid use disorder for individuals using high-potency synthetic opioids

MB Weimer, AA Herring, SS Kawasaki… - Journal of addiction …, 2023 - journals.lww.com
Abstract Treatment of opioid use disorder (OUD) with buprenorphine has evolved
considerably in the last decade as the scale of the OUD epidemic has increased along with …

Opioid agonist treatment for people who are dependent on pharmaceutical opioids

S Nielsen, WC Tse, B Larance - Cochrane Database of …, 2022 - cochranelibrary.com
Background There are ongoing concerns regarding pharmaceutical opioid‐related harms,
including overdose and dependence, with an associated increase in treatment demand …

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder …

ME Socias, E Wood, B Le Foll, R Lim, JC Choi… - …, 2022 - Wiley Online Library
Background and aims Fentanyl is primarily responsible for the current phase of the overdose
epidemic in North America. Despite the benefits of treatment with medications for opioid use …

Estimating the impact of stimulant use on initiation of buprenorphine and extended-release naltrexone in two clinical trials and real-world populations

RR Cook, C Foot, OA Arah, K Humphreys… - Addiction Science & …, 2023 - Springer
Background Co-use of stimulants and opioids is rapidly increasing. Randomized clinical
trials (RCTs) have established the efficacy of medications for opioid use disorder (MOUD) …

“It's my frenemy”: A qualitative exploration of knowledge and perceptions of fentanyl use during the COVID-19 pandemic in people who use drugs at a syringe services …

SB Bass, PJA Kelly, S Pandit-Kerr, J Pilla… - Frontiers in public …, 2022 - frontiersin.org
Background Exacerbated by the COVID-19 pandemic and the proliferation of fentanyl and
fentanyl analogs, overdose deaths have surged in the United States, making it important to …

Fentanyl withdrawal: Understanding symptom severity and exploring the role of body mass index on withdrawal symptoms and clearance

R Luba, J Jones, CJ Choi, S Comer - Addiction, 2023 - Wiley Online Library
Abstract Background and Aims Fentanyl is a highly lipophilic mu opioid receptor agonist,
increasingly found in heroin and other drug supplies, that is contributing to marked …

Opioid use disorder treatment in the age of fentanyl

NP Morris - JAMA Internal Medicine, 2022 - jamanetwork.com
In this issueofJAMA Internal Medicine, Thakrar1 highlights the ways in which hospitals often
do not meet the needs of patients with opioid use disorder (OUD), including undertreating …

A sco** review and consensus recommendations for emergency medical services buprenorphine (EMS-Bupe) programs

AP Joiner, J Wanthal, AN Murrell… - Prehospital …, 2024 - Taylor & Francis
ABSTRACT OBJECTIVES Emergency Medical Services (EMS) agencies are beginning to
provide low-barrier access to treatment for opioid use disorder (OUD) through the …

[HTML][HTML] Differential effect of cannabis use on opioid agonist treatment outcomes: exploratory analyses from the OPTIMA study

L Elkrief, G Bastien, C McAnulty, H Bakouni… - Journal of Substance …, 2023 - Elsevier
Introduction Conflictual evidence exists regarding the effects of cannabis use on the
outcomes of opioid agonist therapy (OAT). In this exploratory analysis, we examined the …

Reconsidering the usefulness of long-term high-dose buprenorphine

L Jain, TW Meeks, CK Blazes - Frontiers in Psychiatry, 2024 - frontiersin.org
Buprenorphine has been successfully used for decades in the treatment of opioid use
disorder, yet there are complexities to its use that warrant attention to maximize its utility …